CALM1 and cancer: CALM1/CALM2/CALM3, the latent IPF-features (Supplementary Table S1) are the known downstream targets of KNG1 (ligand)—BDKRB1 (receptor) signaling (KEGG: hsa05200, Pathways in cancer) (Table 4).